Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,507 | 64,741 | 87,063 | 135,897 | 120,320 |
| Marketable Securities | 222,709 | 259,745 | 198,571 | 416,033 | 459,256 |
| Receivables | 31,952 | 22,429 | 20,595 | 13,896 | N/A |
| Inventories | 21,210 | 20,561 | 14,125 | 5,716 | 0 |
| TOTAL | $381,096 | $392,958 | $339,014 | $584,031 | $593,408 |
| Non-Current Assets | |||||
| PPE Net | 5,421 | 6,707 | 8,610 | 9,583 | 6,333 |
| Investments And Advances | 54,976 | 17,827 | 45,060 | 12,477 | 1,510 |
| Other Non-Current Assets | 32,073 | 36,547 | 36,800 | 36,341 | 21,158 |
| TOTAL | $92,470 | $61,081 | $90,470 | $58,401 | $29,001 |
| Total Assets | $473,566 | $454,039 | $429,484 | $642,432 | $622,409 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,476 | 18,612 | 13,130 | 12,308 | 19,575 |
| Accrued Expenses | 70,295 | 64,622 | 80,773 | 55,227 | 38,716 |
| TOTAL | $100,275 | $86,469 | $96,773 | $69,992 | $60,038 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22,375 | 25,879 | 27,991 | 28,764 | 15,904 |
| TOTAL | $22,375 | $25,879 | $27,991 | $28,764 | $15,904 |
| Total Liabilities | $122,650 | $112,348 | $124,764 | $98,756 | $75,942 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,800 | 75,947 | 58,552 | 57,626 | 55,645 |
| Common Shares | 805 | 676 | 585 | 576 | 516 |
| Retained earnings | -1,428,305 | -1,233,363 | -1,054,432 | -754,468 | -487,979 |
| Other shareholders' equity | 577 | -983 | 51 | 11 | 111 |
| TOTAL | $350,916 | $341,691 | $304,720 | $543,676 | $546,467 |
| Total Liabilities And Equity | $473,566 | $454,039 | $429,484 | $642,432 | $622,409 |